Amedica (Salt Lake City), reported Thursday that it has filed a submission for FDA 510(k) clearance of its Valeo C Interbody with CsC Osteo-Conductive Scaffolding (Valeo CCsC) relating to its composite silicon nitride spinal interbody devices.
It’s truly a futuristic world we live in with technology that not so long ago was only seen in science fiction. Last year, as part of a three-part series Medical Device Daily published, I explored 3-D printing and the potential for that technology, which enables us to make solid objects from...
Molecular diagnostics company Agendia (Irvine, California) reported that it has received FDA 510(k) clearance for its MammaPrint breast cancer recurrence test in FFPE (formalin-fixed paraffin embedded) tissue.
A new drug-eluting spacer infused with steroids may be the answer to an unmet medical need for patients with chronic rhinosinusitis. The device, from SinuSys (Palo Alto, California), is being studied in a clinical trial for use after functional endoscopic sinus surgery (FESS).
